メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
藤田医科大学 ホーム
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
Scopus著者プロファイル
國澤 和生
研究推進ﾕﾆｯﾄ・ﾚｷﾞｭﾗﾄﾘｰｻｲｴﾝｽ分野
h-index
361
被引用数
10
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
2015
2025
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(30)
類似のプロファイル
(6)
フィンガープリント
Kazuo Kunisawaが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Neuroscience
3-Hydroxykynurenine
28%
5-HT1A Receptor
16%
Acetylcholine
9%
Antidepressant
13%
Aquaporin 3
16%
Aryl Hydrocarbon Receptor
16%
Behavior (Neuroscience)
94%
C-Fos
20%
Corticosterone
13%
Dentate Gyrus
32%
Dopaminergic
51%
Eicosanoid Receptor
16%
Feeding Behavior
10%
Galantamine
13%
Hippocampus
26%
Homocysteine
16%
Hypertension
16%
In Vivo
16%
Indoleamine 2,3 Dioxygenase
37%
Interleukin 17
16%
Internal Capsule
16%
Kynurenic Acid
58%
Kynurenine
68%
Kynurenine 3 Monooxygenase
82%
Major Depressive Disorder
34%
Metabolic Pathway
18%
Multiple Sclerosis
18%
Neurogenesis
16%
Neuronal Activity
12%
Nicotinic Acetylcholine Receptor
35%
NMDA Receptor
16%
Nucleus Accumbens
16%
Pervasive Developmental Disorder
38%
Phencyclidine
16%
Prefrontal Cortex
100%
Prepulse Inhibition
16%
Protein Domain
16%
Receptor Antagonist
11%
Serotonergic
35%
Social Behavior
22%
Social Defeat
16%
Social Interaction
20%
Stereotypic Movement Disorder
16%
Striatum
19%
Swimming Test
12%
Trimethylglycine
16%
Tryptophan
49%
Ubiquitination
16%
Valproic Acid
24%
Vesicular Glutamate Transporter 1
16%
Keyphrases
3-hydroxykynurenine
11%
Adolescent Social Isolation
16%
Aquaporin-3 (AQP3)
16%
Aryl Hydrocarbon Receptor Activity
16%
Attention Test
34%
Autism Mouse Model
16%
Behavior Change
16%
Betaine
16%
Brain Regions
25%
Chemokine Ligand 7
9%
Chronic Mild Stress
32%
Chronic Social Defeat Stress
16%
Chronic Stress
16%
Chronic Unpredicted Mild Stress
16%
Cystatin F
16%
D2 Receptor
16%
Dentate Gyrus
16%
Dopamine D1 Receptor
16%
Dopamine D2
16%
Dorsolateral Striatum
16%
F Gene
16%
Focal Loss
16%
Glutamate Transporter 1 (GLT-1)
16%
Glycyrrhizic Acid
16%
KAT2
16%
Kynurenic Acid
30%
Kynurenine 3-monooxygenase
32%
Loureirin C
16%
Lysolecithin
16%
Major Depressive Disorder
13%
Microglia
16%
MiR-874-3p
16%
Mouse Model of Depression
16%
NEDD4
16%
Neurofascin 155
10%
Neuronal Circuits
16%
Object-based Attention
32%
Paranode
16%
Phencyclidine
16%
Plasma Corticosterone
9%
Prefrontal Cortex
51%
Prepulse Inhibition
16%
Quinolinic Acid
9%
Social Impairment
8%
Spatial Cognitive Deficits
16%
Stress-induced
9%
Therapeutic Blockade
16%
Ubiquitination
8%
Ubiquitination Pathway
16%
Xanthurenic Acid
9%
Pharmacology, Toxicology and Pharmaceutical Science
3 Hydroxykynurenine
16%
Acetylcholine
9%
Antidepressant
9%
Aromatic Hydrocarbon Receptor
16%
Attention Deficit Disorder
5%
C57BL 6 Mouse
6%
Chemokine
9%
Cognitive Defect
32%
Corticosterone
13%
Cystine
16%
Demyelination
6%
Dopamine Receptor Stimulating Agent
32%
Enteritis
16%
Galantamine
13%
Glycyrrhetinic Acid
8%
Glycyrrhizin
16%
Immobility
12%
Indoleamine 2,3 Dioxygenase
21%
Inducible Nitric Oxide Synthase
5%
Inflammation
8%
Interleukin 6
8%
Knockout Mouse
15%
Kynurenic Acid
44%
Kynurenine
63%
Kynurenine 3 Monooxygenase
65%
Kynurenine Aminotransferase
6%
Lewis Carcinoma
16%
Lysophosphatidylcholine
16%
Major Depression
31%
Methyllycaconitine
7%
Motor Dysfunction
16%
Mouse
16%
Mouse Model
32%
Nicotinic Acetylcholine Receptor Antagonist
6%
Nicotinic Receptor
30%
Pathophysiology
16%
Phlorizin
16%
Phospholipid
5%
Proteolipid Protein
6%
Reactive Oxygen Metabolite
8%
Serotonin
6%
Sodium Glucose Cotransporter Inhibitor
16%
Soybean
16%
Table Salt
16%
Trimethylglycine
16%
Tryptophan
49%
Tyrosine 3 Monooxygenase
8%
Vesicular Glutamate Transporter 1
16%
Xanthurenic Acid
9%
